Assessing angiogenesis-regulating markers, including VASH1, VASH2, and iNOS, in circulating WBCs provides deeper insights into the tumor microenvironment and immune response in HNSCC, surpassing the limitations of plasma measurements alone. This evidence concerns the gene NOS2 and neoplasm.